Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Visit old site
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 4845
This article has been cited by
1¿Existe relación entre los niveles séricos de vitamina D (25OHD) y el dolor musculoesquelético relacionado con la ingesta de estatinas? Revisión sistemática
Claudia Alejandra Pereda,Maria Betina Nishishinya
Reumatología Clínica.2016;12(6)331
[DOI]
2Dead Meat: Glecaprevir/Pibrentasvir-Induced Statin Myonecrosis
Katherine Wong,Alexander Podboy,Jonathan Lavezo,Aparna Goel
Digestive Diseases and Sciences.2020;65(2)399
[DOI]
3Vitamin D Serum Levels in Patients with Statin-Induced Musculoskeletal Pain
Manuela Pennisi,Giuseppe Di Bartolo,Giulia Malaguarnera,Rita Bella,Giuseppe Lanza,Michele Malaguarnera
Disease Markers.2019;2019(2)1
[DOI]
4Efficacy, safety, Low density lipoprotein cholesterol lowering, and calculated 10-year cardiovascular risk reduction of alirocumab and evolocumab in addition to maximal tolerated cholesterol lowering therapy: a post-commercialization study
Parth Shah,Charles J. Glueck,Naila Goldenberg,Sarah Min,Chris Mahida,Ilana Schlam,Matan Rothschild,Ali Huda,Ping Wang
Lipids in Health and Disease.2017;16(1)1
[DOI]
5Does vitamin D supplementation prevent statin-induced myopathy?
Esther Papp,Edward E. Rylander
Evidence-Based Practice.2019;22(2)21
[DOI]
6Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain
Beth A. Taylor,Lindsay Lorson,C. Michael White,Paul D. Thompson
Atherosclerosis.2017;256(2)100
[DOI]
7Vitamin D Deficiency, Supplementation, and Cardiovascular Health
Naveen Trehan,Luis Afonso,Diane L. Levine,Phillip D. Levy
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine.2017;16(3)109
[DOI]
8Pharmacoeconomics of PCSK9 inhibitors in 103 hypercholesterolemic patients referred for diagnosis and treatment to a cholesterol treatment center
Parth Shah,Charles J. Glueck,Vybhav Jetty,Naila Goldenberg,Matan Rothschild,Rashid Riaz,Gregory Duhon,Ping Wang
Lipids in Health and Disease.2016;15(1)109
[DOI]
9Practical aspects in the management of statin-associated muscle symptoms (SAMS)
Ulrich Laufs,Krysztof J. Filipiak,Ioanna Gouni-Berthold,Alberico L. Catapano,Giuseppe Mandraffino,Pascale Benlian
Atherosclerosis Supplements.2017;26(1)45
[DOI]
10The Vitamin D Assessment (ViDA) study – Design and main findings
Robert Scragg
The Journal of Steroid Biochemistry and Molecular Biology.2020;198(1)105562
[DOI]
11Lifestyle, Lipids, and Cardiovascular Risk Reduction in a Woman With Metabolically Unhealthy Normal Weight
Cynthia Geyer
American Journal of Lifestyle Medicine.2016;10(5)348
[DOI]
12Lifestyle, Lipids, and Cardiovascular Risk Reduction in a Woman With Metabolically Unhealthy Normal Weight
Stephen Devries
American Journal of Lifestyle Medicine.2018;10(5)253
[DOI]
13Association Between Vitamin D Supplementation and Statin-Associated Muscle Symptoms: A Systematic Review
Chong Boon Teo,Pek Yan Tan,Ryan Yong Kiat Tay,Joan Khoo,Gerald F. Watts,Wann Jia Loh
High Blood Pressure & Cardiovascular Prevention.2022;29(4)337
[DOI]
14Targeting PCSK9 as a promising new mechanism for lowering low-density lipoprotein cholesterol
Laura A. Della Badia,Nabil A. Elshourbagy,Shaker A. Mousa
Pharmacology & Therapeutics.2016;164(4)183
[DOI]
15Dyslipidaemia in the elderly: to treat or not to treat?
Niki Katsiki,Genovefa Kolovou,Pablo Perez-Martinez,Dimitri P. Mikhailidis
Expert Review of Clinical Pharmacology.2018;11(3)259
[DOI]
16Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intolerance
StephenJ Nicholls,A Michael Lincoff,Harold E Bays,Leslie Cho,Diederick E Grobbee,John JP Kastelein,Peter Libby,Patrick M Moriarty,Jorge Plutzky,Kausik K Ray,Paul D. Thompson,William Sasiela,Denise Mason,Jaclyn McCluskey,Deborah Davey,Kathy Wolski,Steven E Nissen
American Heart Journal.2021;235(3)104
[DOI]
17Diagnostik und Therapie von statinassoziierten Muskelsymptomen
Ursula Kassner,Stefanie Grunwald,Dominik Spira,Nikolaus Buchmann,Thomas Bobbert,Elisabetta Gazzerro,Tim Hollstein,Simone Spuler,Elisabeth Steinhagen-Thiessen
Der Internist.2021;62(8)827
[DOI]
18Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol =70 mg/dl despite maximal tolerated cholesterol lowering therapy
Charles J. Glueck,Parth Shah,Naila Goldenberg,Marloe Prince,Kevin Lee,Vybhav Jetty,Ashwin Kumar,Michael Goldenberg,Ping Wang
Lipids in Health and Disease.2016;15(1)827
[DOI]
19Is a PCSK9 Inhibitor Right for Your Patient? A Review of Treatment Data for Individualized Therapy
Roman A. Beltran,Kyle J. Zemeir,Chase R. Kimberling,Mary S. Kneer,Michelle D. Mifflin,Tom L. Broderick
International Journal of Environmental Research and Public Health.2022;19(24)16899
[DOI]
20Statin-Associated Muscle Disease: Advances in Diagnosis and Management
Beth A. Taylor,Paul D. Thompson
Neurotherapeutics.2018;15(4)1006
[DOI]
21Statin-related myopathies
David Hilton-Jones
Practical Neurology.2018;18(2)97
[DOI]
22Magnesium Supplementation in Vitamin D Deficiency
Pramod Reddy,Linda R. Edwards
American Journal of Therapeutics.2019;26(1)e124
[DOI]
23Advances in the management of statin myopathy
Antonio Gallo,Jeff Perregaux,Eric Bruckert
Current Opinion in Endocrinology, Diabetes & Obesity.2021;28(2)142
[DOI]
24Myotoxicity of statins: Mechanism of action
Patrick du Souich,Ghislaine Roederer,Robert Dufour
Pharmacology & Therapeutics.2017;175(2)1
[DOI]
25Economic Evaluation of the PCSK9 Inhibitors in Prevention of the Cardiovascular Diseases
Parth Shah
Current Cardiology Reports.2018;20(7)1
[DOI]
26Efficacy and safety of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, alirocumab and evolocumab, a post-commercialization study
Joshua Choi,Amir M Khan,Michael Jarmin,Naila Goldenberg,Charles J Glueck,Ping Wang
Lipids in Health and Disease.2017;16(1)1
[DOI]
27Associations of statin use with motor performance and myalgia may be modified by 25-hydroxyvitamin D: findings from a British birth cohort
Nikhil Sharma,Rachel Cooper,Diana Kuh,Imran Shah
Scientific Reports.2017;7(1)1
[DOI]
28Statin myopathy
Negar Maghsoodi,Anthony S. Wierzbicki
Current Opinion in Cardiology.2016;31(4)417
[DOI]
29Lipids and bariatric procedures Part 2 of 2: scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA)
Harold Bays,Shanu N. Kothari,Dan E. Azagury,John M. Morton,Ninh T. Nguyen,Peter H. Jones,Terry A. Jacobson,David E. Cohen,Carl Orringer,Eric C. Westman,Deborah B. Horn,Wendy Scinta,Craig Primack
Surgery for Obesity and Related Diseases.2016;12(3)468
[DOI]
30Interventions to Improve Statin Tolerance and Adherence in Patients at Risk for Cardiovascular Disease
James T. Reston,Andrew Buelt,Mark P. Donahue,Brian Neubauer,Elena Vagichev,Kristy McShea
Annals of Internal Medicine.2020;173(10)806
[DOI]
31Relationship Between Statin-associated Muscle Symptoms, Serum Vitamin D and Low-density Lipoprotein Cholesterol – A Cross-sectional Study
Harsheen Kaur,Jagjit Singh,Jeet Ram Kashyap,Ravi Rohilla,Harmanjit Singh,Shivani Jaswal,Rajiv Kumar
European Endocrinology.2020;16(2)137
[DOI]
32Relationship Between Statin-associated Muscle Symptoms, Serum Vitamin D and Low-density Lipoprotein Cholesterol – A Cross-sectional Study
Seema Patel,Nadeem Akhtar
European Endocrinology.2018;16(2)739
[DOI]
33Statins everyday versus alternate days: Is there a difference in myalgia rates?
Ramsha Riaz,Aleena Zehra Merchant,Muhammad Salman Ul Haq,Syed Ali Raza Nasir,Yusra Rizvi,Jehanzeb Ahmed Khan,Sara Mohiuddin Zakaria,Hassaan Jawed,Khizar Hamid,Noor-ul-ain Zehra,Madiha Ahmed,Hussain Asif Ali,Kaneez Fatima
Indian Heart Journal.2018;70(4)492
[DOI]
34Curcumin: An effective adjunct in patients with statin-associated muscle symptoms?
Amirhossein Sahebkar,Nikou Saboni,Matteo Pirro,Maciej Banach
Journal of Cachexia, Sarcopenia and Muscle.2017;8(1)19
[DOI]
35Statin Toxicity
Natalie C. Ward,Gerald F. Watts,Robert H. Eckel
Circulation Research.2019;124(2)328
[DOI]
36Statin-related myotoxicity
Vera Fernandes,Maria Joana Santos,Antonio Pérez
Endocrinología y Nutrición.2016;63(5)239
[DOI]
37Important drug-micronutrient interactions: A selection for clinical practice
Uwe Gröber,Joachim Schmidt,Klaus Kisters
Critical Reviews in Food Science and Nutrition.2020;60(2)257
[DOI]
38The impact of statins on physical activity and exercise capacity: an overview of the evidence, mechanisms, and recommendations
Allyson M. Schweitzer,Molly A. Gingrich,Thomas J. Hawke,Irena A. Rebalka
European Journal of Applied Physiology.2020;120(6)1205
[DOI]
39Statin-associated muscle symptoms: Does the benefit outweigh the risk factor?
Shannon M. Laboy,Michael T. PULLEY
Muscle & Nerve.2019;59(5)525
[DOI]
40Bioactive Plant Metabolites in the Management of Non-Communicable Metabolic Diseases: Looking at Opportunities beyond the Horizon
Chandan Prasad,Victorine Imrhan,Shanil Juma,Mindy Maziarz,Anand Prasad,Casey Tiernan,Parakat Vijayagopal
Metabolites.2015;5(4)733
[DOI]
41Trial designs for statin muscle intolerance
Robert S. Rosenson
Current Opinion in Lipidology.2017;28(6)488
[DOI]
42Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)
Peter E. Penson,Eric Bruckert,David Marais,Željko Reiner,Matteo Pirro,Amirhossein Sahebkar,Gani Bajraktari,Erkin Mirrakhimov,Manfredi Rizzo,Dimitri P. Mikhailidis,Alexandros Sachinidis,Dan Gaita,Gustavs Latkovskis,Mohsen Mazidi,Peter P. Toth,Daniel Pella,Fahad Alnouri,Arman Postadzhiyan,Hung-I Yeh,G.B. John Mancini,Stephan von Haehling,Maciej Banach,Julio Acosta,Mutaz Al-Khnifsawi,Fahad Alnouri,Fahma Amar,Atanas G. Atanasov,Gani Bajraktari,Maciej Banach,Sonu Bhaskar,Ibadete Bytyçi,Bojko Bjelakovic,Eric Bruckert,Alberto Cafferata,Richard Ceska,Arrigo F.G. Cicero,Xavier Collet,Magdalena Daccord,Olivier Descamps,Dragan Djuric,Ronen Durst,Marat V. Ezhov,Zlatko Fras,Dan Gaita,Adrian V. Hernandez,Steven R. Jones,Jacek Jozwiak,Nona Kakauridze,Amani Kallel,Niki Katsiki,Amit Khera,Karam Kostner,Raimondas Kubilius,Gustavs Latkovskis,G.B. John Mancini,A. David Marais,Seth S. Martin,Julio Acosta Martinez,Mohsen Mazidi,Dimitri P. Mikhailidis,Erkin Mirrakhimov,Andre R. Miserez,Olena Mitchenko,Natalya P. Mitkovskaya,Patrick M. Moriarty,Seyed Mohammad Nabavi,Devaki Nair,Demosthenes B. Panagiotakos,György Paragh,Daniel Pella,Peter E. Penson,Zaneta Petrulioniene,Matteo Pirro,Arman Postadzhiyan,Raman Puri,Ashraf Reda,Željko Reiner,Dina Radenkovic,Michal Rakowski,Jemaa Riadh,Dimitri Richter,Manfredi Rizzo,Massimiliano Ruscica,Amirhossein Sahebkar,Naveed Sattar,Maria-Corina Serban,Abdullah M.A. Shehab,Aleksandr B. Shek,Cesare R. Sirtori,Claudia Stefanutti,Tomasz Tomasik,Peter P. Toth,Margus Viigimaa,Pedro Valdivielso,Dragos Vinereanu,Branislav Vohnout,Stephan von Haehling,Michal Vrablik,Nathan D. Wong,Hung-I Yeh,Jiang Zhisheng,Andreas Zirlik
Journal of Cachexia, Sarcopenia and Muscle.2022;13(3)1596
[DOI]
43Overview of results from the Vitamin D Assessment (ViDA) study
R. K. R. Scragg
Journal of Endocrinological Investigation.2019;42(12)1391
[DOI]
44The risks and benefits of sun exposure 2016
David G. Hoel,Marianne Berwick,Frank R. de Gruijl,Michael F. Holick
Dermato-Endocrinology.2016;8(1)e1248325
[DOI]
45Functional food red yeast rice (RYR) for metabolic syndrome amelioration: a review on pros and cons
Seema Patel
World Journal of Microbiology and Biotechnology.2016;32(5)e1248325
[DOI]
46Statin intolerance – a question of definition
Engi Abdel-Hady Algharably,Iris Filler,Stephanie Rosenfeld,Katja Grabowski,Reinhold Kreutz
Expert Opinion on Drug Safety.2017;16(1)55
[DOI]
47Is There Really a Relationship Between Serum Vitamin D (25OHD) Levels and the Musculoskeletal Pain Associated With Statin Intake? A Systematic Review
Claudia Alejandra Pereda,Maria Betina Nishishinya
Reumatología Clínica (English Edition).2016;12(6)331
[DOI]
48Rhabdomyolysis and AKI with Atorvastatin and Sitagliptin Use in the Setting of Low 25-Hydroxyvitamin D Levels
Rupinder Singh Buttar,Jasveen Batra,Jacqueline Kreimerman,Melissa Aleta,Michal L. Melamed
Journal of General Internal Medicine.2017;32(10)1156
[DOI]
49Effects of vitamin D on drugs: Response and disposal
Jinfu Peng,Yanan Liu,Jinlian Xie,Guoping Yang,Zhijun Huang
Nutrition.2020;74(10)110734
[DOI]
50Effects of vitamin D on drugs: Response and disposal
Marcin Adam Bartlomiejczyk,Peter Penson,Maciej Banach
Nutrition.2020;74(10)121
[DOI]
51Common Drug Side Effects and Drug-Drug Interactions in Elderly Adults in Primary Care
Susan E. Merel,Douglas S. Paauw
Journal of the American Geriatrics Society.2017;65(7)1578
[DOI]
52Effects of Vitamin D Supplementation in Patients with Statin-Associated Muscle Symptoms and Low Vitamin D Levels
Claudio Carallo,Alessandro Capozza,Agostino Gnasso
Metabolic Syndrome and Related Disorders.2022;20(10)567
[DOI]
53Metabolic Myopathies
Mark A. Tarnopolsky
CONTINUUM: Lifelong Learning in Neurology.2022;28(6)1752
[DOI]
54Statin-related myotoxicity
Vera Fernandes,Maria Joana Santos,Antonio Pérez
Endocrinología y Nutrición (English Edition).2016;63(5)239
[DOI]
55Statin-Associated Muscle Symptoms Among New Statin Users Randomly Assigned to Vitamin D or Placebo
Mark A. Hlatky,Pedro Engel Gonzalez,JoAnn E. Manson,Julie E. Buring,I-Min Lee,Nancy R. Cook,Samia Mora,Vadim Bubes,Neil J. Stone
JAMA Cardiology.2023;8(1)74
[DOI]
56Current Use of Statins for Primary Prevention of Cardiovascular Disease: Patient-Reported Outcomes and Adherence
Scott A. Coon,Emily J. Ashjian,Megan C. Herink
Current Cardiovascular Risk Reports.2016;10(7)74
[DOI]
57An overview of statin-induced myopathy and perspectives for the future
Dragana Nikolic,Maciej Banach,Roberta Chianetta,Luca Marco Luzzu,Anca Pantea Stoian,Camelia Cristina Diaconu,Roberto Citarrella,Giuseppe Montalto,Manfredi Rizzo
Expert Opinion on Drug Safety.2020;19(5)601
[DOI]
58The Interdependency and Co-Regulation of the Vitamin D and Cholesterol Metabolism
Tara Warren,Roisin McAllister,Amy Morgan,Taranjit Singh Rai,Victoria McGilligan,Matthew Ennis,Christopher Page,Catriona Kelly,Aaron Peace,Bernard M. Corfe,Mark Mc Auley,Steven Watterson
Cells.2021;10(8)2007
[DOI]
59Evaluating Statin Tolerability in Historically Intolerant Patients After Correcting for Subclinical Hypothyroidism and Vitamin D Insufficiency
Robert Solomon,Premchand Anne,Jordan Swisher,Beshoy Nazeer,Howard Rosman,Rajendra H. Mehta,James J. Maciejko
High Blood Pressure & Cardiovascular Prevention.2022;29(5)409
[DOI]
60Effects of vitamin D supplementation on adherence to and persistence with long-term statin therapy: Secondary analysis from the randomized, double-blind, placebo-controlled ViDA study
Zhenqiang Wu,Carlos A. Camargo,Kay-Tee Khaw,Debbie Waayer,Carlene M.M. Lawes,Les Toop,Robert Scragg
Atherosclerosis.2018;273(5)59
[DOI]
61The role of vitamin D in statin treated patients complaining of myalagia
Noha Hassanin,Yasser Baghdady,Mohamed Shehata,Ashgan Wagdi
Cor et Vasa.2021;63(1)58
[DOI]
62Oral and Topical Vitamin D, Sunshine, and UVB Phototherapy Safely Control Psoriasis in Patients with Normal Pretreatment Serum 25-Hydroxyvitamin D Concentrations: A Literature Review and Discussion of Health Implications
Patrick J. McCullough,William P. McCullough,Douglas Lehrer,Jeffrey B. Travers,Steven J. Repas
Nutrients.2021;13(5)1511
[DOI]
63Safe use of statins: focus on muscle toxicity
Vana Kolovou,Helen Bilianou,Genovefa Kolovou
Clinical Lipidology.2016;11(1)16
[DOI]
64Comparison of Oral and Injectable Dosage Forms of Vitamin D3 on Resolving Statin-Induced Myopathy: Single Blinded Randomized Controlled Clinical Trial
Reza Ganji,Ahmad Sa’dinpour,Seyed Massoud Seyedian,Saeed Hesam,Nader Afshari,Adeleh Sahebnasagh
SN Comprehensive Clinical Medicine.2021;3(7)1555
[DOI]
65Statin Use and 25-Hydroxyvitamin D Blood Level Response to Vitamin D Treatment of Older Adults
Heike A. Bischoff-Ferrari,Karina Fischer,Endel J. Orav,Bess Dawson-Hughes,Ursina Meyer,Patricia O. Chocano-Bedoya,Otto W. Meyer,Rahel Ernst,Simeon Schietzel,Franz Eberli,Hannes B. Staehelin,Gregor Freystätter,Susanne Roas,Robert Theiler,Andreas Egli,Nicholas M. Wilson
Journal of the American Geriatrics Society.2017;65(6)1267
[DOI]
66Vitamin D Supplementation During Statin Rechallenge in Patients With a History of Intolerance
Alison L. P. Compton,Marc J. Pepin,Daniel R. Katzenberger,Debra W. Kemp,Jamie N. Brown
Annals of Pharmacotherapy.2021;55(6)814
[DOI]
67Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients
Leonardo Calza,Eleonora Magistrelli,Vincenzo Colangeli,Marco Borderi,Ilaria Contadini,Isabella Bon,Maria Carla Re,Pierluigi Viale
AIDS.2017;31(5)681
[DOI]
68Does vitamin D supplementation reduce the risk of statin-associated myalgia?
Susie Wenstrup,Adriana Santana,Amanda Jamal
Evidence-Based Practice.2019;22(9)16
[DOI]
69Neurological Complications of Nutritional Disease
Aparna Polavarapu,Daphne Hasbani
Seminars in Pediatric Neurology.2017;24(1)70
[DOI]
70Geranylgeraniol prevents statin-induced skeletal muscle fatigue without causing adverse effects in cardiac or vascular smooth muscle performance
Jordon C. Irwin,Andrew S. Fenning,Rebecca K. Vella
Translational Research.2020;215(1)17
[DOI]
71Association Between Vitamin D and Statin-Related Myopathy: A Meta-analysis
Qingtao Hou,Caishuang Pang,Yuqin Chen
American Journal of Cardiovascular Drugs.2022;22(2)183
[DOI]
72Statins, Muscle Disease and Mitochondria
Radha Ramachandran,Anthony Wierzbicki
Journal of Clinical Medicine.2017;6(8)75
[DOI]
73Sechs Maßnahmen bei Statin-assoziierten Muskelschmerzen
Gerald Klose
MMW - Fortschritte der Medizin.2018;160(1)40
[DOI]
Feedback
Subscribe

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal